Published in Cancer Weekly, May 27th, 2003
According to recent research from the United States, "Maspin is a unique serine protease inhibitor with a molecular weight of 42 kDa.
"There is very limited data on the prognostic utility of maspin in human breast cancer," wrote S.K. Mohsin and colleagues, Baylor College of Medicine, Breast Center.
"We performed a preliminary study to assess the associations of maspin with other established...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly